Search

everythinglearnresearchcommunity

for

Search:↓

The serum effectively improves hair growth and is well-tolerated for post-cancer hair loss.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Older age, certain hair loss conditions, and specific chemical levels increase the risk of hair loss after a transplant.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Post-COVID syndrome symptoms are common and overlap with general health issues.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Olive leaf extract may help reduce aging signs in postmenopausal women.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Severe COVID-19 often leads to hair loss in India.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Proper management of PTSD with psychotherapy and medication can reduce symptoms.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Vitiligo may be linked to stopping finasteride.

A new skin cancer can develop where shingles once occurred.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

A new microneedle system effectively delivers finasteride to treat hair loss.

Preventive measures during surgery can avoid hair loss complications.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

Older first-time mothers experience more postpartum symptoms and distress than younger ones.

Medicinal plants might help with post-COVID-19 issues, but more research is needed.

Pregnant women with rheumatic diseases often have poor nutrition, needing more folic acid, calcium, and iron, while consuming too much selenium.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.